TTRX
NASDAQ
$10.05
Turn Therapeutics Inc (TTRX)
Turn Therapeutics Inc., is a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company is headquartered in Westlake Village, California.
Sector:
Healthcare
Industry:
Biotechnology
Target: $8 (-20.40%)
Market Cap
$285M
Free Cash Flow Yield
-1.49%
Beta (5Y)
1.33
Price Chart
Valuation
Market Cap$285M
P/B46.70
Profitability
Gross Profit (TTM)-$975K
EBITDA-$3.87M
EPS-$0.14
Financial Health
Debt-to-Equity97%
Free Cash Flow Yield-1.49%
Growth & Risk
Beta (5Y)1.33
Sharpe Ratio0.93